Kentucky
General Assembly

02/10/17	introduced in House
02/14/17	to Health and Family Services (H)
03/01/17	posted in committee
03/02/17	reported favorably, 1st reading, to Calendar with Committee Substitute
03/03/17	2nd reading, to Rules
03/06/17	posted for passage in the Regular Orders of the Day for Tuesday, March 7, 2017
03/07/17	3rd reading, passed 85-1 with Committee Substitute (1)
03/08/17	received in Senate to Health & Welfare (S)
03/15/17	reported favorably, 1st reading, to Calendar with Committee Substitute and committee amendment (1-title)
03/29/17	2nd reading, to Rules

Amendment	House Committee Substitute 1
Summary	Retain original provisions of the bill except to require coverage for at least two abuse abuse-deterrent opioid analgesic drug products on formularies; require compliance with the provisions of KRS 217.822 when prescribing.
Index Headings	Drugs and Medicines - Abuse-deterrent opioid analgesic drug product, substitution for Health and Medical Services - Abuse-deterrent opioid analgesic drug product, substitution for Hospitals and Nursing Homes - Abuse-deterrent opioid analgesic drug product, substitution for Insurance, Health - Abuse-deterrent opioid analgesic drug product, substitution for Pharmacists - Abuse-deterrent opioid analgesic drug product, substitution for Physicians and Practitioners - Abuse-deterrent opioid analgesic drug product, substitution for Public Medical Assistance - Abuse-deterrent opioid analgesic drug product, substitution for Substance Abuse - Abuse-deterrent opioid analgesic drug product, substitution for Medicaid - Abuse-deterrent opioid analgesic drug product, substitution for

Amendment	Senate Committee Substitute 1
Summary	Retain original provisions; add section amending KRS 217.186 to authorize persons to dispense naloxone under standing orders by licensed healthcare providers.
Index Headings	Drugs and Medicines - Abuse-deterrent opioid analgesic drug product, substitution for Health and Medical Services - Abuse-deterrent opioid analgesic drug product, substitution for Hospitals and Nursing Homes - Abuse-deterrent opioid analgesic drug product, substitution for Insurance, Health - Abuse-deterrent opioid analgesic drug product, substitution for Pharmacists - Abuse-deterrent opioid analgesic drug product, substitution for Physicians and Practitioners - Abuse-deterrent opioid analgesic drug product, substitution for Public Medical Assistance - Abuse-deterrent opioid analgesic drug product, substitution for Substance Abuse - Abuse-deterrent opioid analgesic drug product, substitution for Medicaid - Abuse-deterrent opioid analgesic drug product, substitution for

Amendment	Senate Committee Amendment 1
Sponsor	J. Adams
Summary	Make title amendment.
Index Headings	Drugs and Medicines - Abuse-deterrent opioid analgesic drug product, substitution for Health and Medical Services - Abuse-deterrent opioid analgesic drug product, substitution for Hospitals and Nursing Homes - Abuse-deterrent opioid analgesic drug product, substitution for Insurance, Health - Abuse-deterrent opioid analgesic drug product, substitution for Pharmacists - Abuse-deterrent opioid analgesic drug product, substitution for Physicians and Practitioners - Abuse-deterrent opioid analgesic drug product, substitution for Public Medical Assistance - Abuse-deterrent opioid analgesic drug product, substitution for Substance Abuse - Abuse-deterrent opioid analgesic drug product, substitution for Medicaid - Abuse-deterrent opioid analgesic drug product, substitution for